Overview / Abstract: |
Target Audience This activity is intended for primary care providers, internal-medicine specialists, pediatricians, pulmonologists, cardiologists, endocrinologists, gastroenterologists, hepatologists, neurologists, neuromuscular specialists, infectious-disease specialists, obstetricians/gynecologists, rheumatologists, dermatologists, hematologists, oncologists, neonatologists, genetic counselors, social workers, psychologists, nurse practitioners, physician assistants, nurses, and pharmacists Learning Objectives Upon completion of this activity, participants should be better able to: Discuss the role of genetic counselors in educating patients and caregivers on the decision‐making processes for access to gene therapy, financial support, and post‐treatment care Alessandra Biffi, MD Kevin Flanigan, MD Kimberly Goodspeed, MD Stephan A. Grupp, MD, PhD John Kessler, MD Julie A. Parsons, MD Perry B. Shieh, MD, PhD, FAAN |
Expiration |
Apr 29, 2022 |
Format |
Online |
Credits / Hours |
1.0 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty Alessandra Biffi, MD Kevin Flanigan, MD Kimberly Goodspeed, MD Stephan A. Grupp, MD, PhD John Kessler, MD Julie A. Parsons, MD Perry B. Shieh, MD, PhD, FAAN |
Sponsors / Supporters / Grant Providers |
Astellas Gene Therapies; AVROBIO, Inc.; Biogen; CRISPR Therapeutics, Inc.; Helixmith Co., Ltd; Orchard Therapeutics; REGENXBIO Inc.; and uniQure, Inc. |
Keywords / Search Terms |
Relias LLC Relias LLC., FreeCME., Post-Gene Therapy Free CE CME |